P. James B. Dyck

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

P. James B. Dyck, K. M. Kratz, Jeannine L. Karnes et al. · Neurology · 1993 · 1.5K citations

Medicine, Internal Medicine, Neurology +16

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

John L. Berk, Ole B. Suhr, Laura Obici et al. · JAMA · 2013 · 701 citations · Full text

Medicine, Neurology, Molecular Pathology +14

Lower Motor and Primary Sensory Neuron Diseases With Peroneal Muscular Atrophy

P. James B. Dyck · Archives of Neurology · 1968 · 587 citations

Medicine, Genetics, Neurology +15